Summary
Updated Aug 31, 2026
Vikram Karnani is President and CEO of COLLEGIUM PHARMACEUTICAL, INC (COLL). 4 SEC Form 4 filings on record going back to 2024, most recently on 12 February 2026.
Recent Transactions
5Every recent SEC Form 4 transaction Vikram Karnani has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Vikram Karnani files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason P. Rhodes - $124.92M of DYN open-market activity in the last 12 months
- Dirk Kersten - $38.57M of DYN open-market activity in the last 12 months
- Scott Dreyer - $2.02M of COLL open-market activity in the last 12 months
- John A. Fallon - $1.65M of COLL open-market activity in the last 12 months
- Colleen Tupper - $1.22M of COLL open-market activity in the last 12 months
- David Dieter - $716K of COLL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Vikram Karnani?
Vikram Karnani is a corporate insider, tracked as President and CEO of COLLEGIUM PHARMACEUTICAL, INC (COLL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Vikram Karnani last file a Form 4?
The most recent primary Form 4 on record is dated 12 February 2026, one of 4 filings going back to 2024.
Where can I see all of Vikram Karnani's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Vikram Karnani and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
